USB1 (U6 snRNA biogenesis 1) by E. Colombo
  
 




Atlas Genet Cytogenet Oncol Haematol. 2014; 18(9) 678 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS 
 
OPEN ACCESS JOURNAL 
 
USB1 (U6 snRNA biogenesis 1) 
Elisa Adele Colombo 
Genetica Medica, Dipartimento di Scienze della Salute, Universita degli Studi di Milano, Italy (EAC) 
 
Published in Atlas Database: February 2014 
Online updated version : http://AtlasGeneticsOncology.org/Genes/USB1ID44608ch16q21.html 
DOI: 10.4267/2042/54037 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2014 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Abstract 
C16orf57 alias USB1 is the gene which mutations 
underlie poikiloderma with neutropenia (PN) 
syndrome, a rare genodermatosis with autosomic 
recessive inheritance.  
PN patients have an increased risk to develop 
myelodysplasia and acute myeloid leukaemia in the 
second decade of life.  
In 2012, the protein encoded by USB1 has been 
recognised to be a 2H phosphodiesterase involved 
in the processing of U6 snRNA, but its action 
pathway and hence role in the pathogenesis of PN 
has not yet been elucidated. 
Identity 
Other names: C16orf57, EC 3.1.4., hUsb1, 
HVSL1, Mpn1, PN 





According to UCSC database (GRCh37/hg19, 
Feb.2009), USB1 gene maps in the region between 
58035277 and 58055527 bp from pter of 
chromosome 16 with a centromeric-telomeric 
orientation. 
It spans 20 kb and is composed of seven exons 
(GI:305855061; NM_024598.3) (Fig.2). 
Transcription 
Two physiological isoforms, generated by 
alternative splicing (Fig. 2), have been detected in 
normal samples (leucocytes, keratinocytes, 
melanocytes and fibroblasts). The major transcript 
of 2282 nt (isoform 1, NM_024598.3) includes all 
the seven exons of the gene, while the shorter 
isoform of 1217 nt (NM_001204911.1) comprises 
the first three exons and an alternative terminal 
fourth exon located in IVS3 (Arnold et al., 2010). 
 
 
Figure 1. The region on chromosome 16q21 containing USB1 and its neighbouring genes ZNF139 (zinc finger protein 319) and 
MMP15 (matrix metalloproteinase 15) (UCSC database -GRCh37/hg19, Feb 2009). 
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Figure 2. Schematic representation of exon-intron structure of USB1 and the two major transcripts resulting from alternative 
splicing of the two mutually exclusive exons 4. 
 
Several additional transcripts, a few detected in 
cancer samples, are reported in the Ensembl 
database. 
Pseudogene 
No pseudogene for USB1 is known. 
Protein 
Description 
The crystal structure of the human USB1 protein, 
translated by isoform 1 mRNA has been recently 
resolved (Hilcenko et al., 2013).  
The main USB1 protein comprises 265 aa, while 
translation of isoform 4 mRNA predicts a 186 
amino acid protein with a different C-terminus. 
The USB1 protein is characterized by two 
tetrapeptide motifs (HLSL), containing histidine  
and serine residues (H120, S122, and H208, S210) 
which are essential for its catalytic activity. 
Recognition of these motifs by computational 
analysis of the protein sequence has predicted 
USB1 belongs to the 2H phosphodiesterase 
superfamily present in bacteria, archea and 
eukaryotes (Colombo et al., 2012).  
The protein has a globular architecture with two 
juxtaposed lobes with a pseudo two-fold symmetry 
separated by a central groove, which exposes the 
two HLSL motifs of the active site (Fig.3). 
Expression 
USB1 is ubiquitously expressed in humans (Volpi 
et al., 2010). 
The high evolutionary conservation of the protein is 
consistent with the housekeeping function of the 
gene. 
 
Figure 3. Ribbon model of the USB1 protein showing its globular symmetrical conformation with two lobes separated by a 
central groove that exposes the catalytic site containing the two HLSL motifs (encircled). The terminal lobe comprises both the N- 
and the C-termini. Both the terminal and transit lobe consist of antiparallel β-sheets and α-helices (modified from Colombo et al., 
2012). 






Atlas Genet Cytogenet Oncol Haematol. 2014; 18(9) 680 
Localisation 
A nuclear localization of USB1 has been 
demonstrated in HeLa cells (Mroczek et al., 2012); 
both nuclear and mitochondrial localizations have 
been observed for the yeast orthologue (Glatigny et 
al., 2011). 
Function 
Usb1 is a 3'-5' RNA exoribonuclease that trims the 
3' end of the U6 snRNA leading to the formation of 
a terminal 2',3' cyclic phosphate. This post-
transcriptionally modification influences U6 
stability and recycling. Evidence has been obtained 
in yeast where Usb1 depletion leads to reduced 
levels of U6, generalized pre-mRNA splicing 
defects and shorter telomeres. In human use of PN 
cell lines confirmed that U6 is a substrate of USB1, 
but failed to reveal a splicing defect leaving 
unsolved how PN develops (Hilcenko et al., 2012; 
Mroczek et al., 2012; Shchepachev et al., 2012). 
Mutations 
Germinal 
Biallelic mutations in USB1 gene (OMIM*613276) 
cause poikiloderma with neutropenia syndrome 
(OMIM#604173). 
To date, 19 different "loss-of-function" mutations 
have been identified in 38 molecularly tested PN 
patients: 7 non-sense mutations, 6 out-of-frame 
deletions and 6 canonical splice site mutations. The 
latter also include the only missense mutation so far 
reported which however leads to exon skipping 
(Volpi et al., 2010). Recurrent mutations can be 
identified in patients of Navajo, Turkish and 
Caucasian origin attesting a founder effect 
(Colombo et al., 2012). 
Somatic 
No information is currently available on mutations 
of USB1 in sporadic cancers. 
 
Figure 4. Map across the USB1 gene of the currently known 19 mutations. Nonsense mutations are represented with a red 
hexagon, deletions with a yellow star and splicing mutations with a blue triangle. The Table lists for each mutation the intragenic 
position, the description (cDNA nomenclature) and the effect at the protein level. 
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Implicated in 
Poikiloderma with neutropenia 
syndrome (PN) 
Note 
The disease is caused by mutations affecting the 
gene represented in this entry.  
The clinical presentation of PN patients partially 
overlaps that of patients affected with Rothmund-
Thomson syndrome (RTS; OMIM#268400) and 
dyskeratosis congenita (DC; OMIM#613987, 
#613988, #613989, #615190, #224230). 
Disease 
Poikiloderma with neutropenia is a rare inherited 
genodermatosis characterized by skin alterations 
(poikiloderma, nail dystrophy, palmo-plantar 
hyperkeratosis), short stature and non cyclic 
neutropenia.  
In infancy, neutropenia is responsible of the 
recurrent infections, mainly of the respiratory 
system, observed in PN patients and, later in life, 
may lead to myelodysplastic syndrome and acute 
myeloid leukaemia. Squamous cell carcinoma has 
also been reported in PN patients. 
To date, 38 out of 66 PN patients described in 
literature have been molecularly tested and found to 
carry biallelic mutations of the USB1 gene. Most of 
the reported patients carry homozygous mutations, 
attesting inheritance by descent of the same 
ancestral mutation. 
Prognosis 
The knowledge of USB1 3D structure with the 
essential amino acid motifs of the catalytic site 
might enhance the prediction of USB1 mutation 
effects. 
All the mutations reported so far in PN patients (no. 
19) interfere with USB1 function: 16 disrupt the 
catalytic activity due to the loss of one or both 
HLSL motifs, while the remaining 3 mutations, 
although not affecting the catalytically active 
tetrapeptide motifs destroy the internal symmetry of 
the protein. Owing to the restricted number of 
molecularly characterised PN patients no mutation-
phenotype correlations have emerged suitable to 
stratify the patients according to life-long cancer 
risk (myelodysplasia and solid tumours). 
Further studies focussing on the alternative 
transcript are necessary to establish the role of 
isoform 4 on PN pathogenesis and prognosis. 
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